Tannalbin


Indications and Reactions:

Role Indications Reactions
Secondary
Antifungal Prophylaxis 24.2%
Diarrhoea 18.9%
Multiple Myeloma 12.6%
Drug Use For Unknown Indication 11.6%
Fungal Infection 7.4%
Hypertension 7.4%
Plasma Cell Myeloma 5.3%
Nasopharyngitis 4.2%
Panic Disorder 4.2%
Product Used For Unknown Indication 2.1%
Convulsion 1.1%
Upper Respiratory Tract Inflammation 1.1%
Ureteric Rupture 41.7%
Musculoskeletal Stiffness 25.0%
Diarrhoea 16.7%
Overdose 16.7%
Concomitant
Diarrhoea 17.6%
Plasma Cell Myeloma 17.1%
Prophylaxis 8.8%
Hypertension 7.3%
Product Used For Unknown Indication 7.3%
Drug Use For Unknown Indication 6.8%
Insomnia 3.7%
Dementia Alzheimer's Type 3.6%
Pyrexia 3.3%
Pleural Mesothelioma Malignant 2.9%
Constipation 2.6%
Bronchitis 2.4%
Renal Transplant 2.4%
Diabetes Mellitus 2.3%
Epilepsy 2.1%
Cancer Pain 2.0%
Irritable Bowel Syndrome 2.0%
Lupus Nephritis 2.0%
Sedative Therapy 2.0%
Tracheobronchitis Mycoplasmal 2.0%
White Blood Cell Count Decreased 14.4%
Thrombocytopenia 11.1%
Vomiting 7.8%
Platelet Count Decreased 6.7%
Pseudomembranous Colitis 6.7%
Pyrexia 5.6%
Renal Failure Acute 5.6%
Rash 4.4%
Restlessness 4.4%
Aortic Dissection 3.3%
Back Pain 3.3%
Fall 3.3%
Hepatic Function Abnormal 3.3%
Pancreatitis Acute 3.3%
Stomatitis 3.3%
Tracheobronchitis Mycoplasmal 3.3%
Wrong Technique In Drug Usage Process 3.3%
Anal Ulcer 2.2%
C-reactive Protein Increased 2.2%
Drug Interaction 2.2%

Drug Data